Abade dos Santos, F.A.; Carvalho, C.L.; Valente, P.C.L.G.; Armés, H.; Reemers, S.S.; Peleteiro, M.C.; Calonge Sanz, I.; Dalton, K.P.; Parra, F.; Duarte, M.D.
Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit. Vaccines 2022, 10, 356.
https://doi.org/10.3390/vaccines10030356
AMA Style
Abade dos Santos FA, Carvalho CL, Valente PCLG, Armés H, Reemers SS, Peleteiro MC, Calonge Sanz I, Dalton KP, Parra F, Duarte MD.
Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit. Vaccines. 2022; 10(3):356.
https://doi.org/10.3390/vaccines10030356
Chicago/Turabian Style
Abade dos Santos, Fábio A., Carina L. Carvalho, Pâmela C. L. G. Valente, Henrique Armés, Sylvia S. Reemers, Maria C. Peleteiro, Inés Calonge Sanz, Kevin P. Dalton, Francisco Parra, and Margarida D. Duarte.
2022. "Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit" Vaccines 10, no. 3: 356.
https://doi.org/10.3390/vaccines10030356
APA Style
Abade dos Santos, F. A., Carvalho, C. L., Valente, P. C. L. G., Armés, H., Reemers, S. S., Peleteiro, M. C., Calonge Sanz, I., Dalton, K. P., Parra, F., & Duarte, M. D.
(2022). Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit. Vaccines, 10(3), 356.
https://doi.org/10.3390/vaccines10030356
